Principal Consultant
Reviewed By
The global sexually transmitted infections (STI) market size is calculated at US$ 69.67 in 2024, grew to US$ 78.09 billion in 2025, and is projected to reach around US$ 214.36 billion by 2034. The market is expanding at a CAGR of 12.08% between 2025 and 2034.
Sexually transmitted infections are caused by sexually transmissible pathogens, which may lead to various reproductive and sexual health-related problems such as infertility in women, cancer, genitourinary infection, etc. Sometimes, the STIs can be transmitted to the child through the mother, which may further lead to poor neonatal, pregnancy, and child health outcomes, and sometimes stillbirth. More than 30 parasites, bacteria, and viruses can cause more than 1 million STIs every day, as per the WHO. The 4 most common infections are chlamydia, syphilis, trichomoniasis, and gonorrhea. Thus, this increases the need for antibiotic regimens, early vaccination for HP viruses, use of condoms, etc. Furthermore, as modern non-culture-based techniques, the balanced vaginal microbiome is being recognized as a potential preventive approach for STIs.
AI plays an important role in the diagnosis and management of STIs, sexual health, and nonvenereal genital diseases. With the help of patient data analysis and image recognition, the accuracy of diagnosis and screening is enhanced. By maximizing the potential of direct-to-consumer services and e-health, the personalized interventions, targeted screening as well and user-friendliness of services have improved. Predictive analysis, directed interventions at population levels, and real-time epidemiology can be enhanced by utilizing AI in big data. The real-time diagnostic accuracy can be improved by using AI integration with healthcare as a decision support tool. Furthermore, new advances for language accommodation, as well as swift research-to-practice transitions, are being developed.
Increasing Incidences of STI
There is a rise in the incidence rate of STIs. This has increased the demand for treatment and diagnostic options. The industries are also focused on the development of new early diagnostic and treatment options. Similarly, hospitals are using various diagnostic kits for early detection and effective management of STIs along with the increased use of antibiotics. Thus, the government and private sectors are contributing to the same by conducting campaigns and increasing awareness, which in turn drives the sexually transmitted infections (STI) market.
The graph indicates the total number of STI cases diagnosed in 2023. It indicates that there is a continuous rise in chlamydia infection, which increases the demand for diagnosis and treatment options for STIs. Hence, the researchers can focus on developing new diagnostic techniques and treatment options. At the same time, to increase awareness, various programs or campaigns can also be conducted, which will ultimately promote the market's growth.
Lack of Early Diagnosis
Due to the unawareness of the STIs, there is a lack of early diagnosis. Thus, this may lead to complications related to reproductive as well as sexual health and sometimes even cancer. Furthermore, in some cases, the STI doesn’t show any symptoms, due to which it may remain undiagnosed. Hence, there is a need to increase awareness about early diagnosis to avoid any further complications as well as to reduce the risk of STIs.
New Treatment Options
As the incidence of STIs increases, the need for new treatment options also increases. This, in turn, enhances the use of antibiotics, antiviral as well as vaccination to overcome the risk of STIs. Furthermore, there is also a rise in antibiotic resistance, which causes increased demand for new medications. Thus, this increases the need for new therapeutic options and vaccinations as well as personalized and precision medicine. Thus, all these factors contribute to promoting the sexually transmitted infections (STI) market growth.
For instance,
By type, the HIV/AIDS segment dominated the market in 2024. A wide range of populations was affected by HIV/AIDS. This increased the screening and treatment carried out. Furthermore, various awareness programs were also conducted, which enhanced the sexually transmitted infections (STI) market growth.
By type, the human papillomavirus (HPV) segment is estimated to grow significantly at a notable CAGR during the forecast period. The number of patients with HPV is rising, increasing the demand for early diagnosis and vaccinations. Moreover, to reduce the complications associated with it, new treatment options are also being developed.
By treatment type, the antibiotics segment dominated the sexually transmitted infections (STI) market in 2024. Antibiotics were considered to be the first line of treatment for curing STIs. They showed fast action and were at affordable prices, which increased the patient acceptance rates, which in turn raised the market.
By treatment type, the antiviral segment is anticipated to grow significantly during the forecast period. The rate of STIs caused by viruses is increasing, which increases the demand for antiviral drugs. Furthermore, the effective treatment by antiviral drugs is raising the interest to develop new antiviral treatment approaches.
By route of administration type, the oral segment dominated the sexually transmitted infections (STI) market in 2024. The oral route is an ideal route for the administration of drugs as it offers convenience to the patients. Furthermore, due to its cost-effectiveness, it increased the acceptance rates. Thus, it was widely used by the patients.
By route of administration type, the parenteral segment is expected to be the fastest growing during the forecast period. The parenteral route of administration provides rapid action, which improves the efficacy of the treatment. It also reduces the dosing frequency, which enhances patient adherence to the treatment.
By location of testing type, the laboratory testing segment dominated the market in 2024. The laboratory testing provided accurate results. It also confirmed the STIs with or without any symptoms. Furthermore, a wide range of STIs was easily detected. This contributes to the sexually transmitted infections (STI) market.
By location of testing type, the point-of-care (POC) testing segment is estimated to be the fastest growing during the forecast period. POC offers rapid results and is also affordable. Moreover, it is easy to use, which in turn increases patient compliance as well as its demand in the market.
By distribution channel type, the hospital pharmacy segment dominated the sexually transmitted infections (STI) market in 2024. Hospital pharmacies offer a wide range of medications for STIs. It also helped in making the medication readily available, which was prescribed to the patients, and the personalized treatments were also used effectively.
By distribution channel type, the online pharmacy segment is anticipated to be the fastest growing during the forecast period. Online pharmacies are making it possible to get medications delivered at home at affordable prices. Furthermore, it also helps to maintain the patient's privacy. Thus, its use is increasing in STI management.
By end user, the hospital segment dominated the global sexually transmitted infections (STI) market in 2024. Hospitals provide a wide range of diagnostic and treatment options for STIs. It also consisted of specialized staff and technological advances, which helped in complex STI management. Thus, it promoted market growth.
By end user, the homecare segment is predicted to be the fastest growing during the forecast period. Homecare enhances the patient's convenience as well as their privacy. Furthermore, with the help of online pharmacies and rapid testing kits, homecare practices are becoming more effective.
North America dominated the sexually transmitted infections (STI) market in 2024. North America consists of a well-developed healthcare infrastructure with the presence of specialized staff and advanced equipment. At the same time, the diagnostic and treatment options also attracted the patients. Along with these, the government and industries also contributed to the development of new treatment and diagnostic options, enhancing the market growth.
The hospitals in the U.S. are increasing the use of STI diagnosis and treatment options due to increasing patient demands. Furthermore, the industries are also focusing on the development of new approaches for diagnosis and treatment. Along with these, the government is also providing incentives for support.
The hospital in Canada provides a wide range of diagnostic and treatment options. This attracts the population for early diagnosis. Furthermore, the increasing awareness is also enhancing the demand for new STI diagnosis and treatment options.
Asia Pacific is estimated to host the fastest-growing sexually transmitted infections (STI) market during the forecast period. There is a rise in the occurrence of STIs in Asia Pacific, which in turn is increasing the demand for early diagnosis and treatment approaches. At the same time, developing industries are manufacturing various diagnostic options as well as treatment methods. This promotes market growth.
China has a large population, which increases the risk of STIs. Thus, the demand for effective screening and therapeutic options increases. Furthermore, the government supports the development as well as awareness campaigns to reduce the risk associated with STIs.
Due to the rising incidence of STIs, developing industries and hospitals, along with government support, are contributing to the development of new screening and treatment methods. Furthermore, various awareness campaigns are also being conducted, which attract the population for early diagnosis. This, in turn, helps in the effective management of STIs.
Europe is expected to be significantly growing in the sexually transmitted infections (STI) market during the forecast period. Various industries in Europe are experiencing technological advancements due to which the production process is enhanced. At the same time, new point-of-care testing kits are also being developed due to increased demand for diagnostic options. This, in turn, contributes to market growth.
Due to the increased development as well as the adoption of rapid testing kits in the healthcare sectors, there is a rise in the early diagnosis of patients. Furthermore, government schemes or funding are also provided to the patient, which enhances the treatment as well as patient outcome.
Along with increasing new screening and treatment options, the government and private sectors are also conducting programs and campaigns for early diagnosis of STIs. This, in turn, also increases awareness within the population and drives the market.
By Type
By Treatment
By Route of Administration
By Location of Testing
By Distribution Channel
By End User
By Region
Schedule a Meeting
Download Brochure
Table of Content